Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
The level of urinary carcinoembryogenic antigen (CEA) was evaluated in the diagnosis and follow-up of urothelial carcinoma of the bladder. Urinary CEA concentration, cystoscopic findings and the histopathology of an eventually resected bladder tumour were correlated in 177 cases. The sensitivity proved to be 34%, the specificity 82%. Possible correlations with sex, infection, primary tumour or recurrence, differentiation and invasion of an eventually resected tumour and influence of adjuvant therapy were also evaluated. A comparison was made with the results of other authors and different factors which may influence urinary CEA levels are discussed.
D000368:Aged; D002272:Carcinoembryonic Antigen / Q000652:urine*; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000652:urine*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000652:urine; D011863:Radioimmunoassay; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000652:urine*; D014552:Urinary Tract Infections / Q000652:urine
D002272:Carcinoembryonic Antigen